Ads
related to: stages of cognitive development
Search results
Rome students earn Seal of Biliteracy for linguistic diversity
Rome Sentinel· 5 days agoRome Free Academy recently honored 12 students who have demonstrated proficiency in two or more...
Anavex Life Sciences Announces Expansion of Leadership Team
Morningstar· 3 days agoNEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated ...
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2,...
FOX 23 News Albany· 5 days agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage...
Mira Pharmaceuticals Advances Preclinical Trials T | Newswise
Newswise· 6 days ago(NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that ...
Why is immunotheraphy not being used as a tool in the war against Alzheimer's Disease?
Lohud | The Journal News via Yahoo News· 2 days agoLilly will purportedly suggest that donanemab should be taken by all non-cognitively impaired...
Mira Pharmaceuticals progresses Ketamir-2 preclinical trials By Investing.com
Investing.com· 5 days agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical-stage pharmaceutical company, announced...
NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease...
Benzinga· 5 days agoSANTA ANA, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. NKGN ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development ...
NKGen Shares Soar After SNK01 Cleared for Phase 2
Market Watch· 5 days agoBy Dean Seal Shares of NKGen Biotech jumped after the company was cleared to progress its SNK01 cell product for the treatment of Alzheimer's disease into...
The almost unknown food that protects memory
Hardwood Paroxysm· 7 days agoIn a world where health mental Food is becoming more and more valuable, and one food has emerged as a potential memory protector:… Black ginger. Black ginger is often overshadowed by its more ...
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid...
Digital Journal· 5 days agoVicore plans to progress buloxibutid to Phase 2b development in the first half of this year. Stockholm, May 20, 2024- Vicore Pharma Holding AB (STO: VICO), a clinical-< ...